OKUR — ONKURE THERAPEUTICS INC

Ownership history in StepStone Group LP  ·  5 quarters on record

This page tracks every 13F SEC filing in which StepStone Group LP reported a position in ONKURE THERAPEUTICS INC (OKUR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.7% (2024 Q4)
Avg. % of fund
1.91%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 491,938 — 0% 0.72% $1.4M $2.90
2025 Q3 UNCHANGED 491,938 — 0% 0.64% $1.4M $2.75
2025 Q2 UNCHANGED 491,938 — 0% 2.33% $1.2M $2.39
2025 Q1 UNCHANGED 491,938 — 0% 2.17% $2.1M $4.30
2024 Q4 INITIATED 491,938 — — 3.70% $4.2M $8.60
% of Fund (quarterly)    OKUR price (monthly, adj. close)

Other funds also holding OKUR

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 2.79% Rosalind Advisors, Inc. 0.74% Prosight Management, LP 3Y 7Y 0.49% Rangeley Capital, LLC 0.35% Shay Capital LLC 3Y 0.23% ADAR1 Capital Management, LLC 0.21% KOTLER KEVIN 0.13% Aldebaran Capital, LLC 3Y 0.11% NEA Management Company, LLC 3Y 7Y 0.07% Vestal Point Capital, LP 0.06%
← Back to StepStone Group LP Holdings